3-33402820-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014517.5(UBP1):āc.1012A>Cā(p.Thr338Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000144 in 1,594,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014517.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBP1 | NM_014517.5 | c.1012A>C | p.Thr338Pro | missense_variant | 9/16 | ENST00000283629.8 | NP_055332.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBP1 | ENST00000283629.8 | c.1012A>C | p.Thr338Pro | missense_variant | 9/16 | 1 | NM_014517.5 | ENSP00000283629.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000222 AC: 5AN: 225562Hom.: 0 AF XY: 0.0000246 AC XY: 3AN XY: 121842
GnomAD4 exome AF: 0.0000146 AC: 21AN: 1442188Hom.: 0 Cov.: 32 AF XY: 0.0000181 AC XY: 13AN XY: 716702
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.1012A>C (p.T338P) alteration is located in exon 9 (coding exon 9) of the UBP1 gene. This alteration results from a A to C substitution at nucleotide position 1012, causing the threonine (T) at amino acid position 338 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at